Literature DB >> 21134572

TGF-β1: Mediator of a feedback loop in eosinophilic esophagitis--or should we really say mastocytic esophagitis?

J Pablo Abonia, James P Franciosi, Marc E Rothenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134572      PMCID: PMC3220165          DOI: 10.1016/j.jaci.2010.10.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  32 in total

1.  Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response.

Authors:  A Straumann; M Bauer; B Fischer; K Blaser; H U Simon
Journal:  J Allergy Clin Immunol       Date:  2001-12       Impact factor: 10.793

2.  Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression.

Authors:  Jamila Chakir; Joanne Shannon; Sophie Molet; Motonori Fukakusa; Jack Elias; Michel Laviolette; Louis-Philippe Boulet; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

3.  Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease.

Authors:  Richard Kirsch; Rana Bokhary; Margaret A Marcon; Ernest Cutz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-01       Impact factor: 2.839

4.  Esophageal remodeling in pediatric eosinophilic esophagitis.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

Review 5.  TGF-beta and fibrosis.

Authors:  M H Branton; J B Kopp
Journal:  Microbes Infect       Date:  1999-12       Impact factor: 2.700

6.  Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

Authors:  L Hültner; C Druez; J Moeller; C Uyttenhove; E Schmitt; E Rüde; P Dörmer; J Van Snick
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

7.  Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis.

Authors:  Carine Blanchard; Ning Wang; Keith F Stringer; Anil Mishra; Patricia C Fulkerson; J Pablo Abonia; Sean C Jameson; Cassie Kirby; Michael R Konikoff; Margaret H Collins; Mitchell B Cohen; Rachel Akers; Simon P Hogan; Amal H Assa'ad; Philip E Putnam; Bruce J Aronow; Marc E Rothenberg
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

8.  A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.

Authors:  Michael R Konikoff; Richard J Noel; Carine Blanchard; Cassie Kirby; Sean C Jameson; Bridget K Buckmeier; Rachel Akers; Mitchell B Cohen; Margaret H Collins; Amal H Assa'ad; Seema S Aceves; Philip E Putnam; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2006-08-16       Impact factor: 22.682

9.  Transforming growth factor-beta1 and fibrosis in congenital muscular dystrophies.

Authors:  P Bernasconi; C Di Blasi; M Mora; L Morandi; S Galbiati; P Confalonieri; F Cornelio; R Mantegazza
Journal:  Neuromuscul Disord       Date:  1999-01       Impact factor: 4.296

10.  Immunophenotypic characterization and quantification of the epithelial inflammatory infiltrate in eosinophilic esophagitis through stereology: an analysis of the cellular mechanisms of the disease and the immunologic capacity of the esophagus.

Authors:  Alfredo J Lucendo; Marta Navarro; Carmen Comas; Juan M Pascual; Emilio Burgos; Luis Santamaría; Javier Larrauri
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

View more
  13 in total

Review 1.  Emerging therapies for eosinophilic esophagitis.

Authors:  Thomas Greuter; Ikuo Hirano; Evan S Dellon
Journal:  J Allergy Clin Immunol       Date:  2019-11-06       Impact factor: 10.793

Review 2.  Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis.

Authors:  Ikuo Hirano; Seema S Aceves
Journal:  Gastroenterol Clin North Am       Date:  2014-04-16       Impact factor: 3.806

3.  TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis.

Authors:  Lisa Y Beppu; Arjun A Anilkumar; Robert O Newbury; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2014-05-13       Impact factor: 10.793

Review 4.  Eosinophilic Esophagitis: A Primary Disease of the Esophageal Mucosa.

Authors:  J Pablo Abonia; Jonathan M Spergel; Antonella Cianferoni
Journal:  J Allergy Clin Immunol Pract       Date:  2017-03-28

5.  The pathogenesis of eosinophilic esophagitis: beyond the eosinophil.

Authors:  Evan S Dellon
Journal:  Dig Dis Sci       Date:  2013-04-27       Impact factor: 3.199

Review 6.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 7.  T cell co-stimulatory molecules: a co-conspirator in the pathogenesis of eosinophilic esophagitis?

Authors:  Zili Zhang; Thomas J Sferra; Yasemen Eroglu
Journal:  Dig Dis Sci       Date:  2013-03-02       Impact factor: 3.199

Review 8.  Eosinophilic esophagitis in adults: an update on medical management.

Authors:  Ricardo Prieto; Joel E Richter
Journal:  Curr Gastroenterol Rep       Date:  2013-06

9.  High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders.

Authors:  J Pablo Abonia; Ting Wen; Emily M Stucke; Tommie Grotjan; Molly S Griffith; Katherine A Kemme; Margaret H Collins; Philip E Putnam; James P Franciosi; Karl F von Tiehl; Brad T Tinkle; Keith A Marsolo; Lisa J Martin; Stephanie M Ware; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2013-04-19       Impact factor: 10.793

10.  Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.

Authors:  Carol J Henderson; Joanne Ngeow; Margaret H Collins; Lisa J Martin; Philip E Putnam; Juan P Abonia; Keith Marsolo; Charis Eng; Marc E Rothenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-05       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.